Access cutting-edge bk infection treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access bk infection specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bk infection treatment provided free
BK cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Capture System will be safe and effective in decreasing specific viral load in children, adolescents and young adults (CAYA) with refractory BK infection post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) or with primary immunodeficiencies (PID).
Sponsor: New York Medical College
Check if you qualify for this bk infection clinical trial in San Francisco, CA
If you're searching for bk infection treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bk infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.